Recovery Kinetics After Different Sprint Training Protocols (STRecovery)
Launched by UNIVERSITY OF THESSALY · Feb 20, 2021
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Speed is one of the most important physical capacities for many sports, especially those that include speed and power as a major element, and plays a major role on performance. Thus, running speed improvement consists one of the most basic aims of a sprinter's and a power athlete's training program. One of the most commonly used strategies to improve the initial acceleration phase, is resisted sprint training. Evidence suggests that resisted sprint training is more effective in improving acceleration compared to sprint training without additional load. Sprinting is performed through the str...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Srinters or athletes that comprise sprint training in their training programs
- • Absense of musculoskeletal injuries (≥ 6 months)
- • Abstence from use of ergogenic supplements or other drugs (≥ 1 month)
- • Abstence from participation at exercise with eccentric component (≥ 3 days)
- • Abstence from alcohol and energy drings consumption before each experimental trial
- Exclusion Criteria:
- • Musculoskeletal injuries (≤ 6 months)
- • Use of ergogenic supplements or other drugs (≤ 1 month)
- • Participation at exercise with eccentric component (≤ 3 days)
- • Alcohol and energy drings consumption before the experimental trials
About University Of Thessaly
The University of Thessaly is a distinguished academic institution located in Greece, recognized for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes and fostering innovation in medical practices. Its dedicated research teams, equipped with state-of-the-art facilities and expertise across various fields, strive to contribute valuable insights to the scientific community while prioritizing patient safety and ethical standards in all clinical endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trikala, Thessaly, Greece
Patients applied
Trial Officials
Chariklia K Deli, PhD
Principal Investigator
Department of Physical Education and Sport Science, University of Thessaly
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials